Cell and gene therapeutics biotech company Abeona rose 9 ranks this week to 5th position on the leaderboard with a score of 97.35.
Short interest has more than doubled, rising 184.55% to 5.58% of the float. The stock has traded sideways since May but remains down 80% since the beginning of the year.
At ABEO’s Q3 result in November, the company had $23.5 million in cash and short term liquidity but had lost -$9.5 million which widened from -$7.0 million lost in the prior year comparison.
Tech telecom firm Surgepays Inc rose 14 ranks this week to fourth on the leaderboard with a score of 97.57.
Short interest has grown 30.5% and now equates to 67.49% of the total float. During this time shares have risen 12.5%, bringing the year to date gain to 160%.
There is a fierce battle between long and short investors with long investors prevailing. The shorters have gotten it wrong and continue to do so!
During November SURG reported third quarter results where they told investors that they had surpassed the firm’s year-end goal of 200,000 mobile subscribers early. Revenues grew to $36.2 million from $14.5 million in the prior year, but the firm’s underlying adjusted EBITDA loss widened to -$0.8M from -$0.4M.
Online e-commerce retailer Hour Loop has fallen 3 ranks this week on the short squeeze leaderboard from the top with a score of 97.76.
Short interest has risen 14.87% over the month and now equates to 15.59% of the total float.
American visual media company Getty Images has gained 11 ranks this week to have the second highest score of 98.31.
Short interest has grown 33.95% over the month while the stock price has traded relatively flat. Short interest now equates to 84.52% of the float according to NYSE short interest data.
Zero shares are reportedly available and shorted stock has 0.28 days to cover with a borrow fee rate which has skyrocketed to 198.10.
GETY reported third quarter earnings during November with revenue of $230.5 million falling short of consensus estimates. The company also generated EPS of -$0.51 compared to positive $0.08 in the prior year.
Autism spectrum focused biopharma company PaxMedica currently holds the top spot on the short squeeze leaderboard with a score of 98.34 after rising 29 ranks this week.
The stock is currently undergoing a short squeeze with share rising 37.4% in trading on Friday.
Fintel reported a -30.22% decline in short interest to 16.76% of the total float as institutions rushed to cover positions and bank any gains they may have left.
Shorted shares in the stock currently have 0.04 days to cover with zero available shares reported on offer. This has caused the borrow rate fee to rise to 198.10.
PaxMedica’s shares have rallied significantly over the last week after announcing that it had entered into a 30 month investment agreement with Lincoln Park Capital for up to $20 million.
This article originally appeared on Fintel
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.